Author:
Wright Alexi A.,Bohlke Kari,Armstrong Deborah K.,Bookman Michael A.,Cliby William A.,Coleman Robert L.,Dizon Don S.,Kash Joseph J.,Meyer Larissa A.,Moore Kathleen N.,Olawaiye Alexander B.,Oldham Jessica,Salani Ritu,Sparacio Dee,Tew William P.,Vergote Ignace,Edelson Mitchell I.
Subject
Obstetrics and Gynecology,Oncology
Reference55 articles.
1. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer;Vergote;N. Engl. J. Med.,2010
2. Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial;Kehoe;Lancet,2015
3. Neoadjuvant chemotherapy for ovarian cancer: do we have enough evidence?;Kang;Lancet,2015
4. Phase III SCORPION trial (ID number: NCT01461850) in epithelial cancer patients with high tumor load receiving PDS versus NACT: an interim analysis on peri-operative outcome;Fagotti,2015
5. Comparison of treatment invasiveness between upfront debulking surgery versus interval debulking surgery following neoadjuvant chemotherapy for stage III/IV ovarian, tubal, and peritoneal cancers in phase III randomized trial: JCOG0602;Onda;J. Clin Oncol,2014